A clinical perspective on oncoplastic breast conserving surgery

Eva Heeling,Annemiek K. E. van Hemert,Marie-Jeanne T. F. D. Vrancken Peeters

DOI: https://doi.org/10.21037/tbcr-23-40

2023-10-01

Translational Breast Cancer Research

Abstract:A clinical perspective on oncoplastic breast conserving surgery

What problem does this paper attempt to address?

Evolution of breast conserving surgery—current implementation of oncoplastic techniques in breast conserving surgery: a literature review

Inés Torras,Isaac Cebrecos,Helena Castillo,Eduard Mension

DOI: https://doi.org/10.21037/gs-23-454

2024-03-22

Gland Surgery

Abstract:Evolution of breast conserving surgery—current implementation of oncoplastic techniques in breast conserving surgery: a literature review

surgery
Oncoplastic breast surgery: where are we now

Patricia Clark,Ashley DiPasquale,Daniela Cocco,Andrew Brown,Ashley Brown

DOI: https://doi.org/10.1002/jso.27665

2024-12-06

European Journal of Cancer Prevention

Abstract:ABSTRACT In the 1970s, we learned breast conservation therapy (BCT) was not inferior to mastectomy. Early BCT methods could result in deformities that were unacceptable to patients and to their surgeons. By the 1990s, surgeons began to apply the principles of plastic surgery to improve outcomes. The term oncoplastic surgery was first described in the 1990s by Werner Audretsch. We offer a review of principles, techniques, current controversies, and challenges in broadening the utilization of OPS.

oncology
Oncoplastic breast surgery in Europe

Kavitha Däster,Ricardo Pardo Garcia,Yazan Masannat,Ashutosh Kothari

DOI: https://doi.org/10.21037/gs-23-380

2024-02-29

Gland Surgery

Abstract:Keywords: Oncoplastic breast surgery (OPS); surgical training; breast reconstruction

surgery
Oncoplastic surgery for breast cancer

A D Baildam

DOI: https://doi.org/10.1002/bjs.6098

2007-12-28

Abstract:Higher levels of evidence proving difficult

surgery
Oncoplastic surgery in the USA: a review of where we started, where we are today and where we are headed

Lauren M Willcox,Albert Losken,Gabriela Del Pilar Garcia Nores

DOI: https://doi.org/10.21037/gs-23-363

2024-05-30

Abstract:The surgical management of breast cancer has evolved tremendously over the last century and now includes oncoplastic techniques that improve both cosmetic and oncologic outcomes for patients. The purpose of this review is to provide the reader with a broad overview of the history of oncoplastic breast surgery in the United States (USA), and to summarize important patient factors and technical innovations for optimal operative planning in the era of multimodal treatment of breast cancer. The indications for oncoplastic surgery (OPS) have broadened significantly as more women pursue breast conservation with preservation of their native breast tissue. The operative philosophy of OPS is based on fundamental reconstructive principles, with technique selection based largely on tumor size and location. Reduction mammoplasty and mastopexy techniques have become some of the most utilized procedures in OPS due to their versatility to address tumors in almost all areas of the breast. Volume replacement techniques with locoregional perforator flaps continue to gain popularity as a single-stage reconstructive option for women with large tumor to breast ratios, especially with specialized plastic surgeons at high volume, academic centers. The oncologic advantages of OPS have allowed women to avoid mastectomy with improved margin control, re-excision rates, and equivalent overall survival all while preserving the aesthetic outcomes for these patients. Despite the proven benefits of OPS, numerous healthcare systems barriers including insurance status, geographic location, referral patterns, and racial disparities all continue to play a role in access to surgical sub-specialized breast oncology care demonstrating the need for ongoing research and education about oncoplastic principles.
Oncoplasty in Breast Conservative Surgery

WANG Hui-yuan,LI Fei,LUO Bin

DOI: https://doi.org/10.3760/cma.j.issn.1007-631x.2012.04.018

2012-01-01

Abstract:Objective To evaluate oncoplastic techniques on breast conservative surgery.Methods Clinical data of 50 breast cancer patients who received oncoplastic breast conservative surgery from October 2009 to August 2011 were retrospectively analyzed.The indication,methods,outcome and morbility of oncoplastic surgery were assessed. Results All patients had solitary tumors.Twelve patients received neoadjuvant therapy and thirty-eight received upfront surgical therapy.Different oncoplastic surgery techniques were applied based on the location of tumor.There were 20 tumors located in upper outer quadrant receiving lateral radial or horizontal excision; Four lower inner and seven lower outer tumors received V and J shape excision respectively; Three low pole and seven upper pole tumors received inverted T and batwing excision respectively; Six tumors located periareolar area and three tumors located retroareolar area were removed using round block and J shape excision.Two patients experienced postoperative hematoma and three patients had incisional dehiscence followed by secondary infection. Another developed skin ischemia and necrosis. Thirty-five patients have finished the postoperative adjuvant radiotherapy. The appearances of the breasts were satisfactory in all patients except one having deviation of nipple and two patients suffering from dimpling in incisional region.Patients gave high scores about their breast appearance.After 4- 27 months follow-up,two patients had local recurrence and received mastectomy.Other patients were free of recurrence. Conclusions Breast oncoplastic surgery technique benefits those whose tumors located in special area of the breast resulting in a satisfactory cosmetical appearance of the breast.
Clinical analysis of oncoplastic surgical techniques applied in breast-conserving surgery of early stage breast cancer

Wen-yan WANG,Xin WANG,Yang WANG,Ji-dong GAO,Jing WANG,Li-xue XUAN,Yi FANG,Xiang WANG

DOI: https://doi.org/10.11877/j.issn.1672-1535.2015.13.06.14

2015-01-01

Abstract:Objective To evaluate the short-term clinical effect and cosmetic outcome of oncoplastic techniques applied in breast-conserving surgery. Method Clinical data of 25 breast cancer patients who received breast-conserv-ing surgery with gland tissue flap or latissimus dorsi myocutaneous flap following breast reconstruction (observation group), and of another 25 patients that received traditional breast conservative surgery (control group) were retrospec-tively analyzed. The resection range, margin, RTOG cosmetic outcome evaluation, postoperative complications and re-currence or metastasis of the two groups were compared. Result Among the observation group, 21 cases received immediate breast reconstruction with adjacent gland tissue flap and 4 cases were with latissimus dorsi myocutaneous flap. The resection volume of the breast in observation group ranged from 26 to 1105 cm3, with a median volume of 343 cm3, while that of the control group ranged from 15 to 504 cm3, with a median volume of 262 cm3. And there were 3 cases in observation group, and 5 cases in control group that had positive surgical margins confirmed by intra-operative pathologic test of the frozen sections, while no significant differences were observed (χ2=0.504, P=0.478). As for RTOG cosmetic outcome evaluation, number of patients with excellent or good results were 22 (88%) and 20 (80%) in the observation group and control group, respectively, and there were still no significant differences between the two groups (χ2=0.611, P=0.737). One patient in the observation group had multiple bone metastasis in 2 months after surgery, and no recurrence or death was observed after a median follow-up of 5 months (range 2-12 months). Conclusion Application of plastic breast-conserving surgery in early breast cancer on the basis of negative surgical margins may bring about better cosmetic effect, with satisfactory short-term clinical outcome, making it an option that is worth further clinical practice.
The Oncological and Surgical Outcomes of Immediate Oncoplastic Breast Reconstruction With Contralateral Breast Adjustment

Ofir Sahar,Reut Har Zvi,Daphna Barsuk,Yoav Barnea,Or Gelbart Pridan,Keren Hod,Merav Akiva Ben-David

DOI: https://doi.org/10.1093/asj/sjae030

2024-03-19

Aesthetic Surgery Journal

Abstract:Abstract Background Oncoplastic surgery is an expanding approach for managing breast conservation, as it offers improved cosmetic outcomes while maintaining oncological safety. Objectives This study aimed to assess the oncologic and surgical outcomes of patients who underwent oncoplastic procedures at our institution. Methods The study population includes all consecutive breast cancer patients who underwent lumpectomy followed by immediate oncoplastic breast reconstruction with contralateral breast adjustment between 2010 and 2021. Following IRB approval, we evaluated patient demographics, tumor characteristics, surgical details, complications, and follow-up for this group. Quality of life (QOL) and patient-reported outcome measures (PROM) were assessed through questionnaires. Results Following multidisciplinary tumor board discussion 77 patients (82 breasts) underwent oncoplastic surgery. 92.2% underwent breast MRI prior to surgery with mean mass enhancement of 2.35 cm (0-8.5) and non-mass enhancement of 5.77 cm [0-14 cm]), 44% presented with multifocal disease. The final positive surgical margin rate was 2.4%, and all conserved breasts received adjuvant radiation therapy. At 5 years, local recurrence rate was 4.1% for invasive tumors. QOL scores were generally high, with most patients reporting good-excellent cosmetic outcomes and high personal satisfaction with breast appearance and softness. Physicians reported breast symmetry in 89.5%. Conclusions The findings suggest that oncoplastic surgery with contralateral breast adjustment is safe, effective, and excellent option for breast cancer patients wishing for breast conservation even in large or multifocal masses, with favorable oncologic and cosmetic outcomes. The QOL analysis indicates high patient satisfaction. These results support the use of oncoplastic surgery in the management of breast cancer.

surgery
Objective assessment of clinical, oncological and cosmetic outcomes following volume replacement in patients undergoing oncoplastic breast-conserving surgery: protocol for a systematic review

Jesse Hu,Richard M Rainsbury,Ashvina Segaran,Oana Predescu,Pankaj G Roy

DOI: https://doi.org/10.1136/bmjopen-2017-020859

IF: 3.006

2018-07-01

BMJ Open

Abstract:Introduction Oncoplastic breast surgery allows the excision of larger tumours without compromising cosmetic outcome and can be broadly divided into volume displacement and volume replacement techniques. Although oncoplastic surgery has rapidly gained acceptance and is now widely practised, evidence is still lacking especially in patients who underwent volume replacement techniques. As it is a relatively new technique that has been described in the literature in the recent years, a summary of evidence from this literature can help clinicians to understand the clinical, oncologicalandcosmetic outcomes of such procedures. Methods and analysis All original studies including randomised controlled trials, cohort studies, case–control studies and case series involving more than 10 women undergoing partial breast reconstruction using a volume replacement technique will be included. The primary objective is to evaluate the clinical, oncological and cosmetic outcomes following volume replacement in patients undergoing oncoplastic breast-conserving surgery. The secondary objective is to review the patient-reported outcomes (PROMs) associated with oncoplastic breast surgery to help identify any unmet needs and to consider refining the existing PROMs to suit women undergoing volume replacement surgery. A comprehensive literature search, eligibility assessment and extraction of data will be conducted by two trained teams acting independently. Data will be extracted and stored in a database with standardised extraction fields to facilitate easy and consistent data entry. Heterogeneity will be assessed using the Cochrane tests. Ethics and dissemination This systematic review requires no ethical approval. It will be published in a peer-reviewed journal, and it will also be presented at nationalandinternational conferences. PROSPERO registration number CRD42017075700; Pre-results.

medicine, general & internal
Extreme oncoplasty: past, present and future

René Aloisio da Costa Vieira,Regis Resende Paulinelli,Idam de Oliveira-Junior

DOI: https://doi.org/10.3389/fonc.2023.1215284

IF: 4.7

2024-01-30

Frontiers in Oncology

Abstract:Breast surgery has evolved from mastectomy to breast-conserving surgery (BCS). Breast oncoplastic surgery later emerged with the inclusion and development of techniques used in plastic surgery for breast neoplasms. Recently, a new paradigm has been considered for mastectomy candidates with large multifocal and multicentric tumours, designated extreme oncoplasty (EO), which has allowed new techniques to be applied to tumours that would have been ineligible for BCS before. There are few publications and no uniform descriptions grouping all the technical possibilities and new indications together. We performed this a review with the objective of evaluating the indications and surgeries performed in the EO context, representing a new perspective for BCS. We observed new indications as extensive microcalcifications, locally advanced breast carcinoma with partial response to chemotherapy, small to moderate-sized non-ptotic central tumours and extreme ptosis. Small breasts are able for EO since the presence of ptosis. New surgeries are reported as disguised geometric compensation, perforators flaps, local/regional flaps, latissimus dorsi miniflap and partial breast amputation. It is important to decrease barriers to oncoplastic surgery if we want to increase the use of EO and BCS rates.

oncology
Modified oncoplastic lift, lymphatic excision, and reconstruction: Introduction of a novel technique in oncoplastic breast surgery with simple surgical principles

Gabriel De la Cruz Ku,Anshumi Desai,Alexis R. Narvaez-Rojas,Caiwei Zheng,Amber Collier,Lee Weber,Wrood Kassira,Eli Avisar,Mecker G. Möller

DOI: https://doi.org/10.1016/j.surge.2023.12.001

IF: 2.632

2024-01-01

The Surgeon

Abstract:Introduction Oncoplastic surgery is an important component of the management of breast cancer. As prognosis has improved, the need for proficient techniques to achieve disease eradication while maintaining cosmesis for naturally appearing breasts has gained importance. This study describes an easy-to-learn modified oncoplastic technique for patients undergoing breast-conserving treatment. Description of the technique Tumor resection is performed through different peri-areolar, inframammary, or radial incisions . To reduce the size of the surgical defect created after tissue resection, an internal purse-string is performed parallel to the chest wall or base of the wound with subsequent staggering in three or more layers as needed, while maintaining the parallel orientation of the needle. This is followed by the creation and overlapping of internal breast tissue flaps that are rearranged to decrease the dead space with the aim of improving cosmesis. The redundant skin is removed for the skin envelope to maintain shape. The wound is closed in layers. We also describe steps in performing sentinel lymph node and tumor extraction through the same periareolar, inframammary, or radial incisions for tumors located in outer quadrants. Following closure, contour and projection of the breast were maintained without indentation or loss of projection, with a symmetrical appearance to the contralateral side. Conclusion This simplified oncoplastic (MOLLER) technique can be easily learned and used by surgeons who treat cancer patients and have limited oncoplastic training. It uses basic known surgical principles to decrease the size of the defect created while minimizing the need for larger incisions/pedicles.

surgery
Surgical techniques in breast cancer: an overview

Hirah Rizki,Jajini S. Varghese

DOI: https://doi.org/10.1016/j.mpsur.2021.11.016

2022-02-01

Surgery (Oxford)

Abstract:With advancements in oncology and oncoplastic training, the options for treating breast cancer have expanded exponentially over the past two decades. In particular, surgical techniques have advanced to the point where oncological safety and aesthetic outcomes are now the pillars of contemporary breast surgery. Studies have demonstrated that by using oncoplastic techniques, breast conservation has become an alternative for many patients who would otherwise undergo mastectomy. Nonetheless, a considerable cohort of patients will still require, or request, a mastectomy. Surgical options range from a simple wide local excision, therapeutic mammoplasty or volume replacement techniques with a local flap, to mastectomy with whole breast reconstruction using autologous tissue or a prosthetic implant. Deciding between surgical options involves careful consideration of tumour characteristics, patient comorbidities and the potential effects of neoadjuvant and adjuvant treatments. The key message for surgeons is to ensure the chosen surgery does not compromise oncological outcomes and provides an excellent aesthetic outcome with timely healing to prevent delays in commencing adjuvant oncology treatments. In this article, we discuss techniques for breast conservation surgery and reconstructive options after mastectomy. In addition, we detail the safety and influence of neo-adjuvant and adjuvant treatments on surgery.
Oncoplastic resections for breast cancer: the effect of tumor localization and morphological features on the choice of surgical method: history of the issue (Literature review)

G. M. Zapirov,A. D. Zikiryahodzhaev,I. M. Onofriychuk,S. I. Mikhailov

DOI: https://doi.org/10.52581/1814-1471/89/01

2024-07-27

Issues of Reconstructive and Plastic Surgery

Abstract:The development of surgical technology, advances in a chemotherapy and radiation therapy for the treatment of the breast cancer is a solution of not only medical, but also aesthetic problems. A multidisciplinary approach to the treatment of breast cancer has made it possible to use less aggressive tactics of surgical treatment, complementing the operation with other methods of neoadjuvant and adjuvant therapy. Despite the fact is a modern conditions the issue of rehabilitation and preservation of the quality of life of patients after surgical treatment is more acute than ever, today there are no collecting recommendations for the use of breast conserving treatment methods for breast cancer, it is can be useful to adequately assess the risk of tumor recurrence and it is advisable to determine the scope of surgical treatment. However, the experience accumulated by surgeons allows us to identify risk factors for tumor recurrence depending on the characteristics of its location and morphological structure of the tumor. Considering the possibilities of modern neoadjuvant chemotherapy, even with an unfavorable immunohistochemical type of tumor, we can offer patients the choice of breast conserving treatment. This issue is especially acute among young patients, the proportion of whom is increasing every year. In this connection, we can achieve faster treatment of breast cancer, as well as achieve a good aesthetic result with minimal surgical interventions, without the help of foreign materials (implants or other mesh).
Understanding decision-making for and against oncoplastic breast-conserving surgery as an alternative to a mastectomy in early breast cancer: UK ANTHEM qualitative study

Charlotte Davies,Carmel Conefrey,Nicola Mills,Patricia Fairbrother,Chris Holcombe,Lisa Whisker,Joanna Skillman,Paul White,Douglas MacMillan,Charles Comins,William Hollingworth,Shelley Potter

DOI: https://doi.org/10.1093/bjs/znae133

2024-06-12

Abstract:Background: Oncoplastic breast-conserving surgery may allow women with early breast cancer to avoid a mastectomy, but many women undergo more extensive surgery, even when breast-conserving options are offered. The aim of the ANTHEM qualitative study was to explore factors influencing women's surgical decision-making for and against oncoplastic breast-conserving surgery. Methods: Semi-structured interviews were conducted with a purposive sample of women who had received either oncoplastic breast-conserving surgery or a mastectomy with or without immediate breast reconstruction to explore their rationale for procedure choice. Interviews were transcribed verbatim and analysed thematically. Trial registration number: ISRCTN18238549. Results: A total of 27 women from 12 centres were interviewed. Out of these, 12 had chosen oncoplastic breast-conserving surgery and 15 had chosen a mastectomy with or without immediate breast reconstruction. Overwhelmingly, women's decisions were guided by their surgical teams. Decision-making for and against oncoplastic breast-conserving surgery was influenced by three key inter-related factors: perceptions of oncological safety; the importance of maintaining/restoring femininity and body image; and practical issues. Oncological safety was paramount. Women who reported feeling reassured that oncoplastic breast-conserving surgery was oncologically safe were happy to choose this option. Those who were not reassured were more likely to opt for a mastectomy, as a perceived 'safer' option. Most women wished to maintain/restore femininity, with the offer of immediate breast reconstruction essential to make a mastectomy an acceptable option. Practical issues such as the perceived magnitude of the surgery were a lesser concern. Conclusion: Decision-making is complex and heavily influenced by the surgical team. High-quality, accurate information about surgical options, including appropriate reassurance about the short- and long-term oncological safety of oncoplastic breast-conserving surgery is vital if women are to make fully informed decisions.
Oncoplastic Reconstruction in the Setting of Prior Cosmetic Augmentation

Luis Camacho,Carrie K Chu,Melissa P Mitchell,Thuy Nguyen,Arlene Correa,Alexander F Mericli,Carrie K. Chu,Melissa P. Mitchell,Alexander F. Mericli

DOI: https://doi.org/10.1097/prs.0000000000011366

2024-02-20

Plastic & Reconstructive Surgery

Abstract:Background: This study explores the surgical management and reconstruction options for augmented breasts in the context of breast conservation therapy (BCT) for breast cancer. We hypothesized that there would be no difference in the rates of complications, revisions, or patient satisfaction in patients who maintained their breast augmentation versus those that had their implants removed in the context of BCT. Methods: We conducted a retrospective review of 142 patients who underwent BCT at a single center from March 2016 to March 2022. The study included patients who had a preexistent cosmetic augmentation at the time of breast cancer diagnosis and BCT. Patient demographics, clinical and treatment characteristics, breast implant details, reconstructive technique, complications, and revisions were recorded. Patient-reported outcomes were assessed using the BREAST-Q Breast-Conserving Therapy module. Results: Ninety-three (65.5%) patients chose to maintain their implants, while 49 (34.5%) elected to have them removed during BCT. Patients with submuscular implants were more likely to maintain their implants. Oncoplastic mastopexy was associated with higher complication rates, particularly in patients opting for implant downsizing. However, multivariate logistic regression did not identify implant management strategy as an independent predictor for complications or revisions. Surgical site infection was the only predictor of implant explantation. Patient-reported outcomes did not differ significantly between the different implant management cohorts. Conclusions: This study demonstrates that maintaining breast implants during BCT does not increase the risk of complications or revisions. Overall, BCT in augmented women was found to be a safe approach, with high patient satisfaction.

surgery
Pushing the Boundaries for Centrally Located Breast Tumors in Oncoplastic Breast Surgery: A Single Centre Audit

Chaitanyaanand B. Koppiker,Aijaz Ul Noor,Sneha Joshi,Rupa Mishra,Priya Sivadasan,Shama Sharma,Anushree Vartak,Mughda Pai,Chetan Deshmukh,Laleh Busheri,Upendra Dhar,Manasi Munshi

DOI: https://doi.org/10.1101/2024.11.21.24317412

2024-11-25

Abstract:Background Breast Conservative Surgery (BCS) was considered a contraindication for centrally located breast tumor (CLBT), with mastectomy being the preferred treatment. However, advances in oncoplastic techniques now offer promising alternatives by facilitating wider surgical margins and enhancing cosmetic outcomes. This study aims to evaluate surgical, oncological, aesthetic outcome and quality of life (QoL) of oncoplastic breast surgery (OBS) for CLBT. Material and Methods In this study, 136 patients with CLBT were treated with various oncoplastic techniques including Level I (Grisotti Flap), Level II (Therapeutic Mammoplasty), and Level III (Perforator Flap) techniques. Surgical approach selection was guided by breast-size and degree of ptosis. Oncological and cosmetic outcomes were evaluated by surgeons post-operatively. Results The mean age of the patient was 52.7 years (range: 22-79). The Level I oncoplasty technique was utilised in 7 patients (11.7%); Level II (Therapeutic Mammoplasty) oncoplasty in 57 patients (41.9%) and Level 3 (Perforator Flaps) in 52 patients (38.2%). 13.9% of post-operative complications were observed. Cosmetic score revealed good to excellent outcomes regarding the patients' satisfaction toward the surgical procedure. The study observed low rate of local recurrence (4.4%), distant recurrence (5.8%) and metastasis (5.8%). Mortality was 3.6% while all survival (OS) and disease-free survival (DFS) were high at 93.82% and 90.6%, respectively demonstrate the effectiveness of the surgical and adjuvant therapy employed. Discussion OBS offer viable and effective approach for managing CLBT. These procedures not only achieve satisfactory aesthetic results, but also ensure oncological safety, making them a promising alternate to mastectomy for CLBT.

Oncology
Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcome

Annemiek van Hemert,Ariane A. van Loevezijn,Anne Bosman,Carmen A. Vlahu,Claudette E. Loo,Marie-Jeanne T. F. D. Vrancken Peeters,Frederieke H. van Duijnhoven,Iris M. C. van der Ploeg

DOI: https://doi.org/10.1007/s10549-023-07192-8

2024-01-09

Breast Cancer Research and Treatment

Abstract:Breast cancer patients with invasive lobular carcinoma (ILC) have an increased risk of positive margins after surgery and often show little response to neoadjuvant chemotherapy (NAC). We aimed to investigate surgical outcomes in patients with ILC treated with NAC.

oncology
A plastic surgery perspective on the choice between breast conserving surgery with radiotherapy versus mastectomy and reconstruction

Max L. Silverstein,Arash Momeni

DOI: https://doi.org/10.21037/gs-23-506

2024-03-22

Gland Surgery

Abstract:A plastic surgery perspective on the choice between breast conserving surgery with radiotherapy versus mastectomy and reconstruction

surgery
Clinical outcomes and patient-reported outcomes after oncoplastic breast surgery in breast cancer patients: A matched cohort study

Hsuan-Yu Chou,Ling-Ming Tseng,Hsu Ma,Cherng-Kang Perng,Chi-Cheng Huang,Yi-Fang Tsai,Yen-Shu Lin,Pei-Ju Lien,Chin-Jung Feng

DOI: https://doi.org/10.1097/jcma.0000000000001055

2024-01-23

Journal of the Chinese Medical Association

Abstract:Surgery is the recommended treatment for breast cancer, the most common cancer in women in Taiwan and the leading cause of cancer-related deaths. Although breast-conserving surgery (BCS) has good prognosis, in some cases, BCS may cause more significant deformities and interfere with the patient's psychosocial well-being. Oncoplastic breast surgery (OBS) is the treatment option in these cases. This study aimed to determine the outcomes of OBS and BCS regardless of clinical and patient-reported esthetic outcomes.

medicine, general & internal
Oncoplastic Surgery Outcomes in the Older Breast Cancer Population: A Matched-Cohort Comparison Study

Kerry A Gaffney,Manish M Karamchandani,Gabriel De La Cruz Ku,Carly Wareham,Christopher Homsy,Salvatore Nardello,Abhishek Chatterjee,Sarah M Persing

DOI: https://doi.org/10.1097/SAP.0000000000004018

2024-08-01

Abstract:Background: Oncoplastic breast surgery (OBS) is a form of breast conservation surgery (BCS) that involves a partial mastectomy followed by immediate volume displacement or volume replacement surgical techniques. To date, there are few studies evaluating OBS in older patients. Therefore, we sought to determine if outcomes differed between patients 65 years and older versus younger patients who underwent oncoplastic surgical procedures. Methods: A retrospective chart review was performed for all oncoplastic breast operations within a single health system from 2015 to 2021. Patients were stratified by age, with patients 65 years and older (OBS65+) identified and then matched with younger patients (OBS <65) based on BMI. Primary outcomes were positive margin rates and overall complication rates; secondary outcomes were locoregional recurrence (LR), distant recurrence (DR), disease-free survival (DFS), overall survival (OS), and long-term breast asymmetry. Results: A total of 217 patients underwent OBS over the 6-year period, with 22% being OBS65+. Preoperatively, older patients experienced higher American Anesthesia (ASA) scores, Charlson Co-morbidity index (CCI) scores, and higher rates of diabetes mellitus, hypertension, and grade 3 breast ptosis. Despite this, no significant differences were found between primary or secondary outcomes compared to younger patients undergoing the same procedures. Conclusions: Oncoplastic breast reconstruction is a safe option in patients 65 years and older, with overall similar recurrence rates, positive margin rates, and survival when compared to younger patients. Although the older cohort of patients had greater preoperative risk, there was no difference in overall surgical complication rates or outcomes. Supporting the argument that all oncoplastic breast reconstruction techniques should be offered to eligible patients, irrespective of age.

A clinical perspective on oncoplastic breast conserving surgery

Evolution of breast conserving surgery—current implementation of oncoplastic techniques in breast conserving surgery: a literature review

Oncoplastic breast surgery: where are we now

Oncoplastic breast surgery in Europe

Oncoplastic surgery for breast cancer

Oncoplastic surgery in the USA: a review of where we started, where we are today and where we are headed

Oncoplasty in Breast Conservative Surgery

Clinical analysis of oncoplastic surgical techniques applied in breast-conserving surgery of early stage breast cancer

The Oncological and Surgical Outcomes of Immediate Oncoplastic Breast Reconstruction With Contralateral Breast Adjustment

Objective assessment of clinical, oncological and cosmetic outcomes following volume replacement in patients undergoing oncoplastic breast-conserving surgery: protocol for a systematic review

Extreme oncoplasty: past, present and future

Modified oncoplastic lift, lymphatic excision, and reconstruction: Introduction of a novel technique in oncoplastic breast surgery with simple surgical principles

Surgical techniques in breast cancer: an overview

Oncoplastic resections for breast cancer: the effect of tumor localization and morphological features on the choice of surgical method: history of the issue (Literature review)

Understanding decision-making for and against oncoplastic breast-conserving surgery as an alternative to a mastectomy in early breast cancer: UK ANTHEM qualitative study

Oncoplastic Reconstruction in the Setting of Prior Cosmetic Augmentation

Pushing the Boundaries for Centrally Located Breast Tumors in Oncoplastic Breast Surgery: A Single Centre Audit

Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcome

A plastic surgery perspective on the choice between breast conserving surgery with radiotherapy versus mastectomy and reconstruction

Clinical outcomes and patient-reported outcomes after oncoplastic breast surgery in breast cancer patients: A matched cohort study

Oncoplastic Surgery Outcomes in the Older Breast Cancer Population: A Matched-Cohort Comparison Study